GoodRx Holdings (GDRX) Short term Debt (2019 - 2025)
Historic Short term Debt for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $5.0 million.
- GoodRx Holdings' Short term Debt rose 3333.33% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 3333.33%. This contributed to the annual value of $5.0 million for FY2024, which is 4309.78% down from last year.
- GoodRx Holdings' Short term Debt amounted to $5.0 million in Q3 2025, which was up 3333.33% from $5.0 million recorded in Q2 2025.
- GoodRx Holdings' Short term Debt's 5-year high stood at $8.8 million during Q4 2023, with a 5-year trough of $3.8 million in Q3 2024.
- Its 5-year average for Short term Debt is $6.5 million, with a median of $7.0 million in 2021.
- In the last 5 years, GoodRx Holdings' Short term Debt plummeted by 4664.96% in 2024 and then surged by 3333.33% in 2025.
- Over the past 5 years, GoodRx Holdings' Short term Debt (Quarter) stood at $7.0 million in 2021, then changed by 0.0% to $7.0 million in 2022, then increased by 25.01% to $8.8 million in 2023, then tumbled by 43.1% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
- Its last three reported values are $5.0 million in Q3 2025, $5.0 million for Q2 2025, and $5.0 million during Q1 2025.